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We have overexpressed the gene for dihydrofolate reductase (DHFR) from Thermotoga maritima in
Escherichia coli and characterized the biochemical properties of the recombinant protein. This enzyme
is involved in the de novo synthesis of deoxythymidine 5′-phosphate and is critical for cell growth. High
levels of T. maritima DHFR in the new expression system conferred resistance to high levels of DHFR
inhibitors which inhibit the growth of non-recombinant cells. The enzyme was purified to homogeneity
in the following two steps: heat treatment followed by affinity chromatography or cation-exchange chro-
matography. Most of the biochemical properties of T. maritima DHFR resemble those of other bacterial
or eukaryotic DHFRs, however, some are unique to T. maritima DHFR. The pH optima for activity, Km
for substrates, and polypeptide chain length of T. maritima DHFR are similar to those of other DHFRs.
In addition, the secondary structure of T. maritima DHFR, as measured by circular dichroism, is similar
to that of other DHFRs. Interestingly, T. maritima DHFR exhibits some characteristics of eukaryotic
DHFRs, such as a basic pI, an excess of positively charged residues in the polypeptide chain and activa-
tion of the enzyme by inorganic salts and urea. Unlike most other DHFRs which are monomeric or part
of a bifunctional DHFR-thymidylate synthase (TS) enzyme, T. maritima DHFR seems to generally form
a dimer in solution and is also much more thermostable than other DHFRs. It may be that dimer formation
is a key factor in determining the stability of T. maritima DHFR.
Keywords: dihydrofolate reductase; Thermotoga maritima ; thermal stability; purification; expression in
Escherichia coli.
Thermotoga maritima is a hyperthermophilic and strictly an-
aerobic eubacterium with an optimal growth temperature of
80°C [1]. It belongs to the order Thermotogales, a very ancient
and apparently slowly evolving order within the Eubacterial
kingdom. Thermotogales occupy, together with the order Aquifi-
cales, an isolated position in the phylogenetic tree, separated
from other branches of this domain ([2, 3] and references
therein). T. maritima displays several characteristics that are
unique among eubacteria ([2] and references therein); the DNA-
dependent RNA polymerase is resistant up to 1 ìg/ml rifampi-
cin, the membrane contains a characteristic novel ether lipid, the
ribosomes are insensitive to the miscoding-inducing action of
aminoglycoside antibiotics, and it contains a reverse DNA-gy-
rase activity. Thus, the study of T. maritima is of great interest
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from an evolutionary point of view. In addition, most proteins
from this organism that have been characterized to date are in-
trinsically thermostable ([428] and references therein) and are,
therefore, of interest from a biotechnological point of view.
This paper describes studies on dihydrofolate reductase from
T. maritima. Dihydrofolate reductase (DHFR) is a key enzyme
in one-carbon metabolism. It catalyzes the NADPH-dependent
reduction of dihydrofolate (H2-folate). This reaction is a univer-
sal requirement for cell growth; it is one of the sequential reac-
tions in the de novo synthesis of dTMP which is required for
the biosynthesis of DNA. Tetrahydrofolate, the product of the
reaction catalyzed by DHFR, is also involved in the biosynthesis
of purines and some amino acids such as glycine, methionine
and serine [9, 10]. Consequently, DHFR is the target of widely
used antifolate drugs which inhibit cell growth [11214], and the
gene for DHFR is often used as a selection or reporter marker
([15219] and references therein). Due to their biological and
medical importance, genes for DHFR have been cloned from a
wide range of organisms representing all the major kingdoms
[16, 20224], and the corresponding proteins have been studied
extensively in terms of their function, stability and structure
[25229].
The structural gene (dyrA) encoding DHFR of T. maritima
was recently cloned, sequenced and expressed at low levels in
Escherichia coli [23]. We have now subcloned and over-ex-
pressed T. maritima DHFR encoding gene in E. coli using the
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Table 1. Bacterial strains and plasmids used in this study.
Strain or plasmid Genotype/description Source
E. coli strains
INVAF′ F′ endA1 recA1 hsdR17 (r2k , m1k ) supE44 thi-1 gyrA96 relA1 f80lacZ˜M15 ˜(lacZYA-argF)U169º2 Invitrogen
BL21(DE3) F2 hsd S gal (r2B , m2B )(lambdacI857, ind-1, Sam7, nin5, lacUV5-T7 gene/1/) [30]
Plasmids
pKK22323 Apr expression vector, pBR322 ori [33]
pTM8 pKK223-3 with 2.5-kb HindIII insert of Tt. maritima chromosome [23]
pCR2.1 Apr, Kmr cloning vector, ColE1 ori, f1 ori, lac promoter, lacZA fragment Invitrogen
pCRTM Tt. maritima dyr A gene, 0.5 kb insert in pCR2.1 this study
pET3a Apr translation vector, pBR322 ori, T7 promoter, gene 10 translation start site [31]
pTM9 Tt. maritima dyr A gene, 0.5 kb NdeI/BamHI insert in pET3a this study
pET3/BL21(DE3) system [30, 31]. In order to gain more insight
into the molecular evolution of DHFRs, and into structure/func-
tion relationships in this family of enzymes, we have purified
the recombinant protein to homogeneity and characterized its
biochemical properties.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Plasmids and E.
coli strains used in this study are listed in Table 1. Bacteria were
grown at 37°C in medium 853 [32] as liquid medium and with
1.5% agar (Difco) as a solid medium. For bacteria containing
recombinant plasmids, the media contained also 25 ìg/ml ampi-
cillin or 50 ìg/ml kanamycin. E. coli INVAF′ competent cells
from the Original TA Cloning Kit (Invitrogen) were used as
hosts during cloning according to the instruction manual sup-
plied by the manufacturer. Expression of T. maritima DHFR was
carried out in E. coli strain BL21(DE3), using a recombinant
plasmid derived from the expression vector pET3a [30, 31].
DNA manipulation and analysis. Restriction enzymes, T4
DNA ligase and alkaline phosphatase were purchased from
Boehringer Mannheim, and used according to the manufactur-
er’s instructions. All the DNA manipulations and analyses, in-
cluding small-scale plasmid preparation, restriction enzyme di-
gests, agarose (Boehringer Mannheim) gel electrophoresis, DNA
ligation, transformation of E. coli, or DNA fragment purification
from low-melting-temperature agarose gels (BioRad), followed
standard methods [34]. For large-scale preparation of pure plas-
mid, the Nucleobond AX Kit (Macherey-Nagel) was used as
recommended by the manufacturer. The nucleotide sequences of
plasmid pTM9 and of plasmid pTM8 were performed by di-
deoxy chain termination [35] with the T7 DNA Sequencing Kit
(Pharmacia). Nucleotide primers flanking the cloned insert (for-
ward and reverse universal primers) and internal oligonucleotide
primers (DyrS1, 5′-GAA GAC CTC TTC CAG AG-3′ ; DyrS2,
5′-CGT CAC TGT CGA ACC GT-3′ ; DyrS3, 5′-TCC TAT GAC
AGC CAC CC-3′; DyrS4, 5′-CCT TCA CTC GTT TTT TT-3′;
DyrS5, 5′-ACG GTT CGA CAG TGA CG-3′ ; DyrS6, 5′-CAA
AGG AAA GTA AC-3′ ; DyrS7, 5′-GGG TGG CTG TCA TAG
GA-3′) were used to sequence both strands of the DNA insert.
DNA analysis was performed using the Gibco BRL Sequencing
System (Life Technologies).
Polymerase chain reaction. The PCR mix for amplifying
the T. maritima DHFR-encoding gene from pTM8 plasmid con-
tained 200 ìM each nucleotide (dATP, dGTP, dTTP, and dCTP),
20 pmol primers Dyr3 (5′-GCC ATA TGG CAA AAG TGA
TTT TC-3′) and Dyr4 (5′-GCG GAT CCT TAA CGG TGC GAT
TT-3′), 10 mM Tris/HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2,
1 ng pTM8 plasmid DNA as template, and 2.5 U Taq DNA poly-
merase (Boehringer Mannheim)/100 ìl solution. The amplifica-
tion protocol consisted of 5 min at 94°C, followed by 30 cycles
of 0.5 min at 94°C, 0.5 min at 52°C and 1 min at 72°C, fol-
lowed by 10 min at 72°C (Programmable Dri-Block PHC-1
from Techne). The PCR product was analysed using a 1.6%
agarose gel and visualized under ultraviolet light. Dyr3 starts
with a NdeI restriction site which overlaps the ATG start codon,
while Dyr4 ends in a BamHI restriction site after the TAA stop
codon.
Construction of a plasmid for inducible expression of T.
maritima DHFR. Plasmids are described in Table 1. Pure pTM8
plasmid preparation was used as a template to amplify the T.
maritima dyrA-coding sequence by PCR (see above). This DNA
fragment was directly cloned into pCR2.1 vector using the Orig-
inal TA Cloning Kit to yield pCRTM plasmid. The 0.5-kb DNA
fragment corresponding to dyrA was then obtained from pCRTM
by NdeI and BamHI digestion, and cloned into the pET3a vector.
The resulting plasmid, pTM9, carries the dyrA-coding sequence
under control of the T7 RNA polymerase promoter.
Assay of dihydrofolate reductase activity. The standard re-
action mixture contained 0.15 mM NADPH (Boehringer Mann-
heim), 0.05 mM H2-folate (Sigma), and 1210 U enzyme. The
mixture was buffered using 40 mM Mes, pH 6.5, and incubated
at 37°C. Enzyme was incubated with H2-folate and the reaction
was initiated by addition of NADPH. The reaction was moni-
tored by recording the absorption decrease at 340 nm using a
PU8740 UV/VIS scanning spectrophotometer (Philips), in a
temperature-controlled cuvet. The NADPH consumption due to
other enzymes in the crude extract was first determined in a
control cuvet that contained buffer, enzyme solution, and
NADPH, but no H2-folate. This aspecific NADPH consumption
was then subtracted from the total consumption to obtain the
DHFR activity.
Absorbance measurements were converted to units of activ-
ity (U) using the standard relation that one unit DHFR activity
is the amount of enzyme that catalyzes the reduction of 1 ìmol
NADPH/hour under standard assay conditions. Protein concen-
trations were measured by the Lowry method [36], using bovine
serum albumin as a standard.
Thermal stability analysis. The thermal stability of E. coli
DHFR and of recombinant T. maritima DHFR was determined
by heating crude extracts of E. coli non-recombinant and recom-
binant cells for 15 min for a range of temperatures, then assaying
residual activity at 37°C (using standard assay conditions de-
scribed above). The stability of the pure T. maritima DHFR and
the effect of extrinsic factors on thermostability were investi-
gated by incubating the pure enzyme at 80°C for a range of time,
in the presence and in the absence of different agents (Table 4).
For these experiments, T. maritima apo-DHFR was diluted in,
and dialyzed against 50 mM potassium phosphate, pH 7.5.
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pH dependence of T. maritima DHFR activity. The optimal
pH for activity was determined at 37°C in 50 mM Mes, buffered
at different pH values (5.7527.30), for the enzyme in the crude
extract as well as for the pure enzyme. In addition, for the par-
tially purified enzyme (heat treatment for 20 min at 80°C), ac-
tivity was assayed at 60°C in 50 mM potassium phosphate,
pH 6.2027.50, or in 50 mM citrate phosphate, pH 5.2526.70.
These activity measurements could not be monitored in real
time using the scanning spectrophotometer because bubbles ap-
peared in the cuvet when the assay was performed at temper-
atures above 45°C. For this reason, the reaction mixture was
incubated at 37°C or 60°C for 10220 min, and the sample ab-
sorbance was then measured at 340 nm and ambient temperature
in a spectrophotometer. The rate of consumption of NADPH due
to T. maritima DHFR was calculated using the appropriate opti-
cal blanks incubated in the same way; one blank contained
buffer and H2-folate; the other contained buffer, enzyme solution
and NADPH. The blanks were performed in order to measure
the background reaction of the substrates.
Kinetic analysis. Km for both substrates, the inhibitor con-
centration for 50% of maximal activity (IC50) for methotrexate
and trimethoprim and hysteretic behaviour were studied at 37°C,
in 40 mM Mes, buffer pH 6.5. The Km values were measured
on partially purified enzyme whereas other experiments were
performed on the pure enzyme.
For measurements of IC50, in order to obtain a linear kinetic
trace, the enzyme was incubated for 5 min with the inhibitor
solution and NADPH. The reaction was then initiated by adding
H2-folate. For assays involving trimethoprim, which has a low
solubility in water, a concentrated stock solution of inhibitor was
prepared in methanol. In order to account for the slight decrease
in activity caused by the methanol, the control enzyme reactions
for this inhibitor were conducted by adding the appropriate
amount of methanol to the reaction mixture.
Expression and purification of recombinant T. maritima
DHFR. Exponentially growing cultures of E. coli BL21(DE3)
harbouring the pTM9 plasmid were induced with 0.4 mM iso-
propyl-1-thio-â-D-galactopyranoside (IPTG), harvested after 32
4 hours induction, washed in 0.9% NaCl, and sonicated in
40 mM Mes, pH 6.5, for 20 min (Raytheon Sonic Oscillator,
250 W-10 kHz). The extracts were freed of cell debris by centrif-
ugation for 10 min at 17000 g. The crude extract was then
thermodenatured by incubating at 80°C for 20 min. Precipitated
protein was removed by centrifuging for 10 min at 31000 g, re-
suspended in 40 mM Mes, pH 6.5, and again centrifuged. This
step improved the yield of DHFR by recovering additional pro-
tein from the precipitate. Supernatants from both centrifugation
steps were pooled and applied to a methotrexate-agarose
(Sigma) column (Pharmacia XK16/20) equilibrated with 10 mM
Mes, pH 6.5. The column was then washed with 200 ml starting
buffer followed by 125 ml 200 mM sodium carbonate, pH 10.3.
The enzyme was eluted using 5 ml 200 mM sodium carbonate,
pH 10.3, containing 2 mg/ml H2-folate or methotrexate, fol-
lowed by 30 ml 20 mM sodium carbonate, pH 10.3, and frac-
tions of 4 ml were collected. Fractions containing DHFR activity
were combined, dialyzed overnight against 332 L 10 mM so-
dium carbonate, pH 10.3, and concentrated from <20 ml to
<4 ml in an Amicon concentrator (YM-10 membrane). Due to
the high affinity of T. maritima DHFR for the ligands used in
the elution step, they remained bound to the enzyme. The prepa-
rations were thus DHFR2H2-folate complexes when eluting
with H2-folate and DHFR-methotrexate complexes when eluting
with methotrexate. The complex DHFR-methotrexate-NADPH
was obtained by adding NADPH to a solution of DHFR-metho-
trexate complex.
Pure T. maritima apo-DHFR (i.e. DHFR with no bound li-
gands) was obtained as described above, except that after heat
denaturation, the protein was subjected to cation exchange chro-
matography instead of affinity chromatography. The partially
purified protein was applied to a 4.6 mm3100 mm column of
Poros 20 HS resin (Perseptive Biosystems, Inc.) that had been
pre-equilibrated in 25 mM Tris/25 mM bisTrispropane, pH 8.0.
Due to its high pI, T. maritima DHFR binds to the cation-ex-
change resin under these conditions. A salt gradient of 021M
NaCl was then applied to the column, and the activity of eluted
fractions was tested. The enzyme eluted as the major peak from
the column at <4002550 mM NaCl. SDS/PAGE of the eluted
fractions revealed that the centre of the peak of eluted T. mari-
tima DHFR contained . 95% pure apoprotein.
Mass spectrometry. Purified T. maritima apo-DHFR and
DHFR2H2-folate complex were dialyzed against 10 mM ammo-
nium bicarbonate, pH 7.9, then lyophilized. Protein was then re-
dissolved in 50:50 acetonitrile/H2O (by vol.) containing <10%
formic acid and subjected to electrospray ionization mass spec-
trometry using a Quattro II Mass Spectrometer fitted with an
electrospray source (MicroMass).
SDS/PAGE. Sodium dodecyl sulfate/polyacrylamide gel
electrophoresis was performed using a Pharmacia PhastSystem
with discontinuous buffer system and a continuous 8225% gra-
dient gel. Gels were stained with Coomassie brilliant blue. Pro-
tein standards (Pharmacia, 0.5 ìg each on the gel) used for esti-
mation of subunit molecular masses were phosphorylase b
(94 kDa), albumin (67 kDa), ovalbumin (43 kDa), carbonic an-
hydrase (30 kDa), trypsin inhibitor (20.1 kDa) and A-lactalbumin
(14.4 kDa).
Isoelectric focusing gel electrophoresis. The isoelectric
points of T. maritima apo-DHFR and of the complexes DHFR-
methotrexate and DHFR-methotrexate-NADPH were deter-
mined by IEF gel electrophoresis using the Pharmacia PhastSys-
tem with broad range gels and using the Hoefer Mighty Small
II Vertical Gel Electrophoresis Unit with broad-range IEF gels
from Novex. Broad range pI markers (Pharmacia) were supple-
mented with horse heart cytochrome c (Sigma) as a high pI
marker (pI 5 10.3).
Native molecular-mass determination. The molecular
mass of T. maritima DHFR2H2-folate complex was determined
under native conditions by gel filtration using a Pharmacia
FPLC system fitted with a Superose P12 HR 10/30 column in
the following buffers: 100 mM sodium carbonate pH 10.3,
40 mM sodium carbonate plus 0.1 M NaCl, pH 10.3, 50 mM po-
tassium phosphate pH 7.5, 100 mM citrate/HCl, pH 4.3, and
40 mM citrate/HCl plus 0.1 M NaCl, pH 4.3. About 50 ìg pure
DHFR2H2-folate (in 0.2 ml) was applied to the gel-filtration
column that had been equilibrated and calibrated in each buffer
using the following standards (Pharmacia, about 100 ìg each
protein): aldolase (158 kDa), bovine serum albumin (67 kDa),
ovalbumin (43 kDa), chymotrypsinogen A (25 kDa) and ribo-
nuclease A (13.7 kDa).
Dynamic light-scattering measurements. The hydrody-
namic radius of T. maritima apo-DHFR and of the complexes
DHFR2H2-folate and DHFR-methotrexate were measured by
dynamic light scattering (DLS). Samples contained <5 mg/ml
protein in 75 mM potassium phosphate, pH 6.5. The DLS ap-
paratus used in this study is typical of most systems. Light from
a 50-mW Nd: YAG laser (model 532-50, Coherent) of wave-
length 532.0 nm was focused onto a standard four-sided clear
optical cuvette (Helma). The scattered light was collimated by
two 400 ìm diameter pinholes placed 35 cm apart and detected
by a photomultiplier (model 9863, EMI Electronics, Ltd). Pho-
ton counting and pulse shaping were performed using a quantum
photometer (model 1140, Princeton Applied Research). Final
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autocorrelation was performed by an autocorrelator (model
1096, Langley-Ford). The fitting procedures to recover size dis-
tributions are detailed by Hallett et al. [37].
Circular dichroism. CD spectra of T. maritima apo-DHFR
and of DHFR-methotrexate complexes were acquired on a J715
Spectropolarimeter (Jasco). Samples contained 0.525 mg/ml
protein in 75 mM KH2PO4/K2HPO4, pH 6.5, and measurements
were made at ambient temperature. Secondary-structure analysis
of apo-DHFR was performed using the k2d method which uses a
Kohonen neural network to extract the secondary structure from
circular dichroism spectra at 2002240 nm [38, 39].
RESULTS
dyrA gene subcloning. The recombinant plasmid pTM8 [23],
consisting of expression vector pKK22323 and a 2.5-kb HindIII
fragment of T. maritima DNA, carries the incomplete pyrB and
gtlD genes flanking the complete dyrA gene. In E. coli cells
transformed with the pTM8 plasmid, the host and the T. mari-
tima DHFR can be easily distinguished because the recombinant
protein is unaffected by heat treatments which completely inacti-
vate E. coli DHFR.
Since only low levels of recombinant DHFR were obtained
using pTM8, the T. maritima dyrA gene was subcloned and over-
expressed in E. coli in order to facilitate further characterization
of the protein. This was achieved by first amplifying the coding
part of the dyrA gene by PCR using pTM8 plasmid as template.
The PCR product, ending in NdeI and BamHI restriction sites,
was then cloned into the pCR2.1 vector (Table 1). Next, the
NdeI2BamHI subfragment was cloned into the pET3a expres-
sion vector, yielding pTM9 plasmid, which was used to trans-
form E. coli BL21(DE3) cells. The NdeI restriction site was de-
signed to overlap with the ATG start codon so that this would
be preceeded by the Shine-Dalgarno sequence of the new vector.
Both strands of the dyrA gene on the pTM8 plasmid and
on the pTM9 plasmid were sequenced using the dideoxy-chain
termination method, in order to confirm that no mutations had
been introduced by the Taq DNA polymerase during PCR. One
mutation was found in the subcloned dyrA gene; base T at posi-
tion 379 was replaced by C. As a consequence, the deduced
polypeptide contained a Leu at position 127 rather than a Phe
residue. The residue at position 127 is not strictly conserved, but
is hydrophobic in many different sequences (for example, Leu
in type-III DHFR from Salmonella typhimurium, Val in E. coli
DHFR, and Phe in mammalian DHFRs). Based on sequence
alignments of T. maritima DHFR with DHFRs whose structures
have been determined by X-ray crystallography (E. coli DHFR
[40], Lactobacillus casei DHFR [40] and human DHFR [41,
42]), residue 127 in T. maritima DHFR is located in a loop at
the periphery of the protein structure, just outside the active site.
A conservative mutation at such a location would be unlikely to
have a large effect on activity or stability. Thus, the mutant pro-
tein has been purified and further characterized.
Enzyme production and resistance to DHFR inhibitors. The
specific activity of partially purified T. maritima DHFR in heat-
treated (20 min at 60°C) extracts of E. coli cells harbouring
pTM9 was found to be 130-fold higher than the activity of anal-
ogous extracts of cells harbouring pTM8, and there was no de-
tectable activity in similar extracts of non-recombinant cells.
Optimum expression was obtained when cultures were induced
by IPTG at the beginning of the exponential growth (A660 <0.35)
and harvested after 4 hours of induction. Within 30 min of in-
duction, cell growth ceased and the A660 of induced cultures re-
mained approximately constant for several hours (data not
Table 2. Purification of T. maritima DHFR−H2-folate or DHFR-
methotrexate complexes from pTM9 recombinant E. coli cells. The
thermodenaturation step is heat treatment for 20 min at 80°C. Enzyme
activity was assayed under standard conditions (see Materials and
Methods).
Purification Total Total Specific Recovery Puri-
step protein activity activity fication
mg U U/mg % -fold
Crude extract 1037 9292 9.0 100 1.0
Thermo-
denaturation 248 7430 30.0 80 3.3
Methotrexate-
agarose 36 6240 173 67 19.2
Fig. 1. SDS/PAGE of the purified recombinant dihydrofolate reduc-
tase of T. maritima. Lane 1, molecular mass markers, 0.5 ìg each pro-
tein; lane 2, 0.8 ìg DHFR. Molecular masses of proteins are in kDa.
The gel was stained with Coomassie brilliant blue.
shown). In contrast, induction had no effect on the growth of E.
coli non-recombinant cells. The lag in growth of induced cul-
tures of E. coli recombinant cells could indicate that the overpro-
duction of T. maritima DHFR from the plasmid monopolizes the
transcriptional and translational machinery of E. coli, or that this
overproduction is toxic.
E. coli recombinant cells were grown in the absence and in
the presence of DHFR inhibitors (trimethoprim and methotrex-
ate). Inhibitor was added to a final concentration of 1 mM and
at an A660 of 0.3, together with IPTG. Whereas wild-type E. coli
cells stopped growing 324 h after addition of inhibitor, the A660
of E. coli pTM9 cultures followed the same pattern as cultures
without inhibitor, except that the lag in growth was longer (data
not shown). Resistance to methotrexate was slightly more
marked than resistance to trimethoprim suggesting at first sight
that trimethoprim might be a more potent inhibitor for the T.
maritima DHFR (but see kinetic properties).
Enzyme purification. The results of a typical purification of T.
maritima DHFR from 25 g (wet mass) E. coli pTM9 cells, culti-
vated as described in Materials and Methods, are summarized in
Table 2. Owing to the high amount of T. maritima DHFR in the
cells, its high thermal stability compared to E. coli proteins, and
the high specificity of methotrexate-agarose for DHFRs, only
two purification steps were required to obtain pure recombinant
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Table 3. Gel-filtration FPLC chromatography of pure DHFR−H2-
folate complex. The column was first calibrated in each buffer using
protein standards from Pharmacia. Proteins were detected by measuring
the absorbance at 280 nm and DHFR activity was assayed under stan-
dard conditions (see Materials and Methods).
Elution buffer Mass Structure
Da
Citrate/HCl, pH 4.3 20 400 monomer
Citrate/HCl, pH 4.3 1 0.1 M NaCl 33 000 dimer
Mes, pH 6.5 1 0.1 M NaCl 36 350 dimer
Potassium phosphate, pH 7.5 39 000 dimer
Sodium carbonate, pH 10.3 33 300 dimer
Sodium carbonate, pH 10.3 1 0.1 M NaCl 36 550 dimer
DHFR. The heat-treatment step inactivated E. coli DHFR so that
pure T. maritima DHFR2H2-folate could be isolated in the sub-
sequent affinity-chromatography step. A high pH (10.3) was
necessary to release the enzyme from the methotrexate-agarose
resin. The purification procedure resulted in 20-fold purification
of T. maritima DHFR to homogeneity (Fig. 1), with a final yield
of 67%. The specific activity of the final T. maritima DHFR
preparation was 173 U/mg. In this particular purification, over-
expressed T. maritima DHFR represented approximately 5% of
the total protein content in the crude extract.
T. maritima apo-DHFR was also purified in two steps; heat
treatment of crude extracts (as described above), followed by
cation-exchange chromatography using a Poros 20 HS strong
cation-exchange resin. Small quantities of some high molecular
mass proteins co-eluted with T. maritima DHFR from the cation
exchange resin. Initial attempts to separate these components by
gel-filtration chromatography were unsuccessful due to prob-
lems with aggregation of apo-DHFR (see results for DLS). How-
ever, by retaining only those fractions with highest DHFR activ-
ity at the peak of the T. maritima DHFR elution profile, it was
possible to obtain .95% pure apo-DHFR. This material was
used for subsequent biophysical measurements. Since large
quantities of apo-DHFR were discarded in this procedure, no
estimate of yield of pure protein has been made for this pro-
cedure. However, typically several milligrams pure protein could
be obtained from 1 litre culture.
Molecular mass, subunit structure, and N-terminal amino
acid sequence determination. The molecular mass of T. mari-
tima DHFR obtained by both affinity chromatography and cat-
ion-exchange chromatography procedures was determined by
electrospray ionization mass spectrometry. The molecular mass
of the protein was found to be 19 20063 Da in both cases.
These experimental results are in excellent agreement with the
expected molecular mass of 19203 Da, based on the deduced
amino acid sequence of the protein.
Polyacrylamide gel electrophoresis in denaturing conditions
(SDS/PAGE) of pure T. maritima DHFR revealed two major
bands (Fig. 1) at 19.5 kDa and 33 kDa. These could correspond
to a monomeric and a dimeric structure, respectively, of the en-
zyme. Indeed, thermostable enzymes are often more resistant to
denaturing agents such as SDS than mesophilic proteins. In or-
der to investigate this, the two bands obtained by SDS/PAGE
were submitted to Edman degradation; both N-terminal amino
acid sequences were identical (AKVIFVLAMDV) and corre-
sponded to the N-terminus predicted from the nucleotide se-
quence of dyrA. Thus, the bands do indeed correspond to a mo-
nomeric and dimeric form of the protein. Similar reassociation
of monomers after SDS denaturation of a thermostable enzyme
Fig. 2. Protein size analysis by DLS. The sample contained <5 mg/ml
T. maritima DHFR-methotrexate complex in 75 mM KH2PO4/K2HPO4,
pH 6.5, at ambient temperature. The main species in solution has a
hydrodynamic radius of 4.7 nm and there is a minor component with a
radius of <16.5 nm.
Fig. 3. CD spectra. Far-ultraviolet CD spectra of T. maritima apo-DHFR
(solid line) and DHFR-methotrexate complex (dashed line). Samples
contained <5 mg/ml protein in 75 mM KH2PO4/K2HPO4, pH 6.5, at
ambient temperature.
was also observed for ornithine carbamoyltransferase of Pyro-
coccus furiosus [43].
As DHFRs from other species are usually monomers or part
of a bifunctional DHFR-TS enzyme, we further investigated
oligomerization of T. maritima DHFR by gel-filtration chroma-
tography (Table 3). Based on these experiments, recombinant T.
maritima DHFR generally forms a dimer of two 19-kDa sub-
units. A monomeric form of the enzyme is observed only at low
pH (4.3) in the absence of NaCl. Thus, the pH of the eluting
buffer affects the quaternary structure of the enzyme and NaCl
promotes dimer formation at both low and high pH values.
Dynamic light scattering measurements. DLS measurements
were made to determine the hydrodynamic radius of T. maritima
apo-DHFR and of the complexes DHFR2H2-folate and DHFR-
methotrexate in solution. The solution of apo-DHFR was very
slightly cloudy and DLS detected small amounts of aggregated
material with a broad range of sizes. DLS is extremely sensitive
to the presence of large particles because these scatter light
much more strongly than small particles. Since large species do-
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Fig. 4. Thermal stability of E. coli DHFR and T. maritima DHFR.
The residual DHFR activity was assayed at 37°C after 15 min incubation
of a crude extract at different temperatures ; E. coli non-recombinant
cells giving the DHFR activity due to the enterobacterial enzyme (d)
and E. coli recombinant cells harbouring pTM9 plasmid giving the
DHFR activity due to the expression of the DHFR encoding gene of T.
maritima in E. coli (j). Data are expressed relative to the activity mea-
sured in the extract that was not incubated, deducing the E. coli DHFR
activity from the total DHFR activity in E. coli recombinant cells.
Table 4. Thermal stability of the pure T. maritima DHFR at 80°C.
The pure enzyme was in 50 mM potassium phosphate, pH 7.5.
[Enzyme] Effector added Half-life
mg/ml M min
0.2 none 68272
0.1 none 58262
0.02 none 60264
0.1 NADPH (1024) .360
0.1 H2-folate (1024) .240
0.1 NaCl (0.1) 59263
0.1 urea (1) 26228
minated the scattering profile of the apo-DHFR sample, it was
not possible to determine the hydrodynamic radius for apo-
DHFR. Similar aggregation of apo-DHFR has been observed for
human DHFR (Nirmala, N. R., unpublished results).
In contrast to apo-DHFR, DHFR2H2-folate and DHFR-
methotrexate complexes formed clear solutions, in which the
main species could be measured and had hydrodynamic radiuses
of 5.0 nm and 4.9 nm (Fig. 2). Both solutions also contained
very small quantities of aggregated material (size in the order of
micrometers) ; this material precipitated over a period of several
days when the solutions were kept at ambient temperature. The
radii for DHFRs in crystal structures are 222.5 nm ([44] and
references therein), which are about 50% the size of radii mea-
sured for T. maritima DHFR by DLS.
Circular dichroism measurements. Far-ultraviolet CD mea-
surements were performed in order to investigate the secondary
structure of T. maritima DHFR in solution. Spectra were ac-
quired for both apo-DFHR and DHFR-methotrexate complexes
(Fig. 3). The spectra of T. maritima DHFR are remarkably simi-
lar to corresponding spectra for E. coli DHFR [45, 46]. Overall,
the spectra for T. maritima DHFR are also very similar to spectra
for Lactobacillus casei DHFR [47] and chicken liver DHFR
[48], although there are some minor differences.
A quantitative estimate of the secondary structure of apo-
DHFR was obtained using the k2d program, which uses a neural
network-based method to predict protein secondary structure
based on CD data (see Materials and Methods). According to
this method, apo-DHFR consists of approximately 14% helix,
38% â sheet and 48% coil structure. The prediction was within
the acceptable error limits as reported by the program. The pre-
dicted secondary structure of T. maritima DHFR can be com-
pared with the known secondary structure of DHFRs in crystal
structures: E. coli DHFR (pdb code 1ra9), 25% helix, 31% â-
sheet and 44% coil ; Lactobacillus casei DHFR (pdb code 3dfr),
24% helix, 31% â sheet and 45% coil ; chicken liver DHFR
(pdb code 8dfr), 23% helix, 32% â sheet and 45% coil; human
DHFR (pdb code 1dhf), 22% helix, 31% â sheet and 47% coil.
Thus, the predicted secondary structure of T. maritima DHFR is
very similar to the known secondary structure of other bacterial
and eukaryotic DHFRs.
Thermal properties of the enzyme. The thermal stability of T.
maritima DHFR was investigated by measuring residual activity
after incubating crude extract at different temperatures (Fig. 4).
100% activity was retained after heating the extract for 15 min
at 75°C, whereas E. coli DHFR was completely inactivated by
a 15-min incubation at 55°C. 65% T. maritima DHFR activity
remained after 15 min incubation at 90°C, and boiling for
15 min resulted in complete inactivation (Fig. 4).
The thermal stability of pure DHFR was investigated at
80°C (T. maritima optimal growth temperature). The stability of
the pure enzyme was similar to that of enzyme in the crude
extracts and did not appear markedly concentration-dependent
(Table 4). The presence of either substrate during the heat treat-
ment strikingly protected the enzyme and this effect was more
pronounced for NADPH than for H2-folate. In contrast, the half-
life at 80°C was reduced by a factor two in 1M urea (Table 4).
Addition of NaCl resulted in a biphasic denaturation process
(data not shown); 40% of the activity was lost during the first
30 min incubation (half-life identical to the control, Table 4),
but the 60% remaining activity was stable at least until 90 min.
This feature could be caused by increased formation of dimer in
the presence of NaCl.
pH dependence of enzyme activity and solubility. T. maritima
DHFR activity was measured as a function of pH at 37°C and
at 60°C, as described in Materials and Methods. The optimal
pH for activity of T. maritima DHFR is about 6.5 at 37°C, and
about 6.3 at 60°C. These pHs are quite similar to optimal pHs
for DHFRs from other species (Table 5). However, in contrast
to DHFRs from human, chicken and E. coli which have two
maxima, the pH profile for T. maritima DHFR has only one
maximum.
The solubility of purified, concentrated DHFR2H2-folate is
pH-dependent. This complex is very soluble at basic pH
(pH 8.5210.3). At lower pH, however, it precipitates in a revers-
ible manner. The precipitated complex could be resolubilized by
raising the pH (e.g. by using sodium carbonate, pH 10.3).
The isoelectric pHs of apo-DHFR, DHFR-methotrexate and
DHFR-methotrexate-NADPH were investigated using IEF gel
electrophoresis (Table 5). Due to technical difficulties in measur-
ing pI values greater than pH 9, it was only possible to deter-
mine that the pI of apo-DHFR was greater than pH 9. Ligand
binding resulted in a lowering of the pI of the apo-protein to
pH 8.1 for DHFR-methotrexate and to 7.0 for DHFR-methotrex-
ate-NADPH. The lowered pIs for the complexes are similar to
results obtained for other DHFRs, however, all pI values for T.
maritima DHFR are considerably higher than corresponding pIs
measured for other DHFRs (see Table 5). Interestingly, the pI of
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Table 5. Kinetic and Biochemical parameters of DHFRs from different sources.
Source and references Km for IC50 for Optimal pI
pH
H2-folate NADPH metho- trimetho- apo- DHFR- DHFR2 DHFR-
trexate prim DHFR metho- H2-folate metho-
trexate trexate-
NADPH
ìM
Toxoplasma gondii [51] 0.6 0.5 8 6.4
Pneumocystis carinii [52, 53] 2.3 3.0 0.0001 20 7.0
Candida albicans [54] 4.0 3.0 6.3 7.1
Chicken [48] 0.2 1.8 4.0 & 7.4 8.4 7.4 5.5
Human [28, 53, 55, 56] 0.03620.12 0.2520.16 0.08 22300 4.5 & 7.5 7.7 6.2
Lactobacillus casei [57] 1.5 20.7
Escherichia coli [13, 29, 56, 58] 0.2729.0 1.0524.4 0.003 0.00820.05 4.0 & 7.0 4.7
Thermotoga maritima (this study) 0.3 4.0 0.07 300 6.5 .9 8.1 7.0
Fig. 5. Effect of inorganic salts and of denaturing agents on the activ-
ity of the pure T. maritima DHFR-H2-folate complex. The DHFR ac-
tivity was assayed under standard conditions in the presence of the
following different concentrations of inorganic salts: (a) NaCl (j), KCl
(h) or CaCl2 (d); denaturing agents (b) and (c) ; urea (b and c, j), SDS
(c, h) or guanidine hydrochloride (c, d). Data are expressed relative to
the activity measured in the absence of effectors.
T. maritima DHFR is more similar to those of vertebrate DHFRs
than bacterial DHFR.
Kinetic properties of the enzyme. The Km values for both sub-
strates were determined using partially purified enzyme (first
step of purification). Due to the limit of sensitivity of the assay,
the very low Km values are only approximate. The Km for
Table 6. Amino acid composition of DHFRs from different sources.
38 protein sequences for DHFRs were obtained from all dyr sequence
entries reported in the Genbank and EMBL databases. Partial sequences
were not included, and the TS encoding part was eliminated from the
sequences corresponding to DHFR-TS bifunctional enzymes. Amino
acid compositions were calculated using the SAPS-server for statistical
analysis of protein sequences [60] available at http://ulrec3.unil.ch/soft-
ware/SAPS form.html.
Source of the Number (L1V1I1M1F) (R1K)/(D1E)
sequences of se- hydrophobic charged
quences residues residues
average ratio
average range
%
Higher eukaryotes 10 30.5 28.6231.7 1.0
Fungi and protozoan 11 29.1 26.2231.2 1.2
Bacteria 15 30.3 27.6234.9 0.8
Halobacterium volcanii 1 24.1 0.5
Thermotoga maritima 1 36.0 1.2
Total 38 30.0 24.1236.0
NADPH is <4 ìM while that for H2-folate is <0.3 ìM. These
values are similar to the Km values of DHFRs from other species
(Table 5).
Preliminary experiments showed that T. maritima DHFR ex-
hibits hysteretic behaviour, as has been observed for E. coli
DHFR [29, 49]. When the reaction was initiated by adding
NADPH or enzyme solution, a linear consumption of substrates
with time was observed. However, when the enzyme was incu-
bated with NADPH (for about 10 s) and the reaction initiated by
adding H2-folate, the reaction rate increased with time (data not
shown). This kind of kinetic behaviour was also observed by
Baccanari and Joyner [50] for E. coli DHFR, although Penner
and Frieden [50] did not observe hysteretic behaviour for E. coli
DHFR incubated with either substrate. As for the enzyme from
E. coli [50], the hysteretic latency of T. maritima DHFR dimin-
ished with increasing enzyme concentration.
In order to investigate the affinity of T. maritima DHFR for
inhibitors of DHFRs, in vitro inhibition experiments were per-
formed on pure apo-DHFR. IC50 values for different inhibitors
were determined under standard conditions. The IC50 values are
<0.07 ìM for methotrexate and <300 ìM for trimethoprim.
Compared to IC50 concentrations for DHFRs from other sources
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(Table 5), the IC50 value for methotrexate is relatively high, and
that for trimethoprim is elevated compared to that of bacterial
E. coli DHFR. The results for T. maritima DHFR may, however,
be deceptively high due to assays being performed at 37°C, far
from the optimal temperature for activity. Also, methotrexate is
an inhibitor 4000-fold more potent in vitro than trimethoprim.
However, as described above, the effect of these inhibitors on
the growth of E. coli pTM9 was comparable. It is thus likely
that trimethoprim enters the cells more easily.
Effect of salts and denaturing agents on enzyme activity. It
has been observed previously that vertebrate DHFRs and the
protozoan DHFR from Toxoplasma gondii can be activated by a
diverse group of agents, such as inorganic salts and chaotropes
([59] and references therein, [51]). Since T. maritima DHFR is
a representative of one of the oldest line of descent among eu-
bacteria and its properties are similar to both eukaryotic and
prokaryotic DHFRs ([23] and this paper), the effects on enzyme
activity of NaCl, KCl, and CaCl2 as well as of urea, SDS and
guanidine hydrochloride were investigated.
T. maritima DHFR is activated 1.4-fold at concentrations of
NaCl and KCl of 402200 mM (Fig. 5 a) and is as active in the
presence of 500 mM salt as in the absence of salt. In contrast,
CaCl2 inhibits enzyme activity at concentrations above 20 mM
(Fig. 5 a).
As for the DHFRs from chicken liver [59] and from T. gondii
[51], T. maritima DHFR activity increases in the presence of
urea (Fig. 5b), however the effect is less pronounced (1.5-fold)
than for the eukaryotic DHFRs (4-fold and 5-fold). T. maritima
DHFR is more active in 7 M urea than in the absence of this
denaturing agent. In contrast, a decrease in activity (Fig. 5 c) was
observed in the presence of low concentrations of SDS
(. 7 mM) or guanidine hydrochloride (.10 mM).
Amino acid composition. The amino acid compositions of
DHFRs representing all the major kingdoms were compared
with that of T. maritima DHFR. In spite of the low identity
between DHFRs, some interesting features were observed. The
thermostable DHFR from T. maritima contains the highest pro-
portion of hydrophobic residues (L, V, I, M, and F) among all
other known DHFRs (Table 6). However, in T. maritima DHFR
as well as in almost all fungal and protozoan DHFRs and several
other eukaryotic DHFRs, the amount of positively charged resi-
dues (R and K) is higher than the amount of negatively charged
residues (D and E), resulting in an excess of positive charges.
In contrast, in all the bacterial DHFRs, except for Mycoplasma
species, the inverse situation is observed (Table 6). The large
excess of negatively charged residues observed in the DHFR
from Halobacterium volcanii (the only archaeal DHFR charac-
terized up to now) has to be related to the halophily of this
species.
DISCUSSION
T. maritima DHFR was expressed in E. coli using the pET3a
expression vector. The enzyme was purified to homogeneity
from recombinant cells by a two-step purification procedure, and
characterized for a number of biochemical and biophysical prop-
erties.
As shown previously, T. maritima DHFR exhibits a typically
thermophilic temperature profile [23]. The protein is intrinsically
thermostable ; its stability did not show any striking concentra-
tion dependence, but the presence of substrates (NADPH or H2-
folate) markedly improved enzyme stability, even at a rather low
concentration.
Based on molecular-size measurements by gel-filtration
chromatography, DHFR2H2-folate complex appears to exist pri-
marily in a dimeric form under most solution conditions. These
results differ from those obtained for other DHFRs, which have
been found to be monomeric. Measurements of hydrodynamic
radii of T. maritima DHFR by DLS showed that the radius of the
enzyme is roughly twice that expected from crystal structures
of various monomeric DHFRs. These data also suggest that T.
maritima DHFR forms a dimer in solution. The dimerization
could have some bearing on the thermostability. Oligomerization
has been proposed as a general mechanism by which proteins
may increase their stability in thermophilic organisms [61, 62].
The far-ultraviolet CD spectra obtained for T. maritima
DHFR are very similar to corresponding spectra for E. coli, L.
casei and chicken liver DHFRs. In addition, the predicted sec-
ondary structure of T. maritima DHFR based on the CD spectra
is very similar to the known secondary structure of bacterial and
eukaryotic DHFRs in crystal structures. Thus, despite the rather
low sequence similarity between T. maritima DHFR and other
DHFRs [23], and the dimeric state of T. maritima DHFR versus
the monomeric state of other DHFRs, the secondary structure of
T. maritima DHFR in solution seems to be very similar to the
structures of DHFRs from other species. These results are in
agreement with the secondary structure prediction for T. mari-
tima DHFR obtained by the program PhDPredict which bases
secondary-structure predictions on alignments of homologous
proteins [63, 64]. According to this prediction, residues in all
the secondary-structural elements observed in other DHFRs are
strongly conserved in T. maritima DHFR. Thus, all the above
results suggest that dimerization probably causes little change in
the secondary structure of the protein.
It is known from X-ray crystallography that binding of H2-
folate and methotrexate causes little structural change in both
bacterial and eukaryotic DHFRs ([44] and references therein).
Since similar and rather limited changes occur in the CD spectra
of T. maritima DHFR, L. casei DHFR and E. coli DHFR upon
ligand binding, it is likely that binding also causes little change
in the structure of T. maritima DHFR.
The reaction catalyzed by T. maritima DHFR shows hyster-
etic behaviour for the H2-folate-initiated reaction. Non-linear ki-
netics have also been observed for E. coli DHFR [49, 50]. The
hysteretic phenomenon implies that there are two coexisting
forms of the enzyme, one predominant in the absence of the
substrate, and the other predominant in the presence of the sub-
strate. This kind of kinetic behaviour requires slow interconver-
sion between two forms of the enzyme which differ in their
enzymatic activity [65]. It is possible that this interconversion
involves oligomerization of T. maritima DHFR, although it may
also be caused by slow conformational changes in the active
site; for example, Bystroff and Kraut [66] observed conforma-
tional changes in E. coli DHFR upon the binding of NADPH.
However, enzyme-concentration dependency of hysteresis is
usually indicative of a polymerization step with the monomer
being the less active enzyme species [49].
Interestingly, T. maritima DHFR is activated by urea, a prop-
erty of vertebrate DHFRs [59] that has also been observed for
the protozoan DHFR from T. gondii [51], but never for a bacte-
rial DHFR. The structural basis for this activation is not known;
however, based on trypsin digestions and fluorescence measure-
ments, Fan et al. [59] have proposed that the activation of
chicken liver DHFR in dilute denaturants is accompanied by a
loosening up of the protein structure, particularly in the vicinity
of the active site.
As T. maritima DHFR is activated by KCl or NaCl, even at
high concentration, and inhibited at low concentration of CaCl2,
monovalent cations are probably responsible for activation. Acti-
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vation of DHFRs by inorganic salts has often been observed [51,
55, 57, 59]. Contrary to urea, NaCl did not reduce the thermal
stability of T. maritima DHFR, thus the mechanism of activation
by NaCl is likely to be different than that by urea.
In conclusion, T. maritima DHFR is the first thermophilic
DHFR to be characterized. It resembles in many ways both eu-
karyotic and bacterial DHFRs, consistent with its phylogeny (on
the basis of 16 S RNA comparisons) as one of the most ancient
lines of descent not only in the Bacterial domain but in the living
world at large. This DHFR also has some unique properties, it
forms a dimer under most conditions, has a high thermal sta-
bility and a high content of hydrophobic residues. It will be
very interesting to determine the tertiary structure of T. maritima
DHFR, these studies are in progress. Knowledge of the structure
of the protein will provide insights into the phylogeny of DHFRs
and the role of dimerization in thermostability and thermophily.
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